Amy Newman, Ph.D.
Dr. Amy Newman is Scientific Director of the NIDA Intramural Research Program, Chief of the Molecular Targets and Medications Discovery Branch, and Director of the Medications Development Program. She conducts research on the design, synthesis, and evaluation of small molecules that are potential treatment medications for substance use disorders, with a focus on cocaine, methamphetamine, and opioid use disorders. Dr. Newman obtained her Ph.D. in medicinal chemistry from Virginia Commonwealth University.
About This Talk
The U.S. is experiencing a drug overdose crisis. We have medications to prevent overdose and treat opioid and alcohol use disorders, but we have no medications for the treatment of cocaine or methamphetamine use disorders. Dr. Newman will describe the challenges and potential solutions in developing effective medications to treat substance use disorders. She will also highlight exciting research that is fundamental to medication discovery.
Audiences: college, community